181 related articles for article (PubMed ID: 3279793)
1. Phenotypic and genotypic analysis of a human medulloblastoma cell line and transplantable xenograft (D341 Med) demonstrating amplification of c-myc.
Friedman HS; Burger PC; Bigner SH; Trojanowski JQ; Brodeur GM; He XM; Wikstrand CJ; Kurtzberg J; Berens ME; Halperin EC
Am J Pathol; 1988 Mar; 130(3):472-84. PubMed ID: 3279793
[TBL] [Abstract][Full Text] [Related]
2. Establishment and characterization of the human medulloblastoma cell line and transplantable xenograft D283 Med.
Friedman HS; Burger PC; Bigner SH; Trojanowski JQ; Wikstrand CJ; Halperin EC; Bigner DD
J Neuropathol Exp Neurol; 1985 Nov; 44(6):592-605. PubMed ID: 4056828
[TBL] [Abstract][Full Text] [Related]
3. Amplification of the c-myc gene in human medulloblastoma cell lines and xenografts.
Bigner SH; Friedman HS; Vogelstein B; Oakes WJ; Bigner DD
Cancer Res; 1990 Apr; 50(8):2347-50. PubMed ID: 2180567
[TBL] [Abstract][Full Text] [Related]
4. Characterization of five new cell lines derived from human primitive neuroectodermal tumors of the central nervous system.
Pietsch T; Scharmann T; Fonatsch C; Schmidt D; Ockler R; Freihoff D; Albrecht S; Wiestler OD; Zeltzer P; Riehm H
Cancer Res; 1994 Jun; 54(12):3278-87. PubMed ID: 8205550
[TBL] [Abstract][Full Text] [Related]
5. Establishment of a human medulloblastoma cell line (BO-101) demonstrating skeletal muscle differentiation.
Giangaspero F; Pession A; Trerè D; Badiali M; Galassi E; Ceccarelli C; Cavazzana A; Betts CM; Paolucci P; Stella M
Tumori; 1991 Jun; 77(3):196-205. PubMed ID: 1862545
[TBL] [Abstract][Full Text] [Related]
6. Phenotypic analysis of four human medulloblastoma cell lines and transplantable xenografts.
He XM; Skapek SX; Wikstrand CJ; Friedman HS; Trojanowski JQ; Kemshead JT; Coakham HB; Bigner SH; Bigner DD
J Neuropathol Exp Neurol; 1989 Jan; 48(1):48-68. PubMed ID: 2535715
[TBL] [Abstract][Full Text] [Related]
7. [Establishment and biological characterization of human medulloblastoma cell lines].
Yamada M; Shimizu K; Tamura K; Okamoto Y; Matsui Y; Moriuchi S; Park K; Mabuchi E; Yamamoto K; Hayakawa T
No To Shinkei; 1989 Jul; 41(7):695-702. PubMed ID: 2818910
[TBL] [Abstract][Full Text] [Related]
8. Abnormal expression of REST/NRSF and Myc in neural stem/progenitor cells causes cerebellar tumors by blocking neuronal differentiation.
Su X; Gopalakrishnan V; Stearns D; Aldape K; Lang FF; Fuller G; Snyder E; Eberhart CG; Majumder S
Mol Cell Biol; 2006 Mar; 26(5):1666-78. PubMed ID: 16478988
[TBL] [Abstract][Full Text] [Related]
9. Tumorigenicity of cerebellar primitive neuro-ectodermal tumors in athymic mice correlates with poor prognosis in children.
Vassal G; Terrier-Lacombe MJ; Lellouch-Tubiana A; Valery CA; Sainte-Rose C; Morizet J; Ardouin P; Riou G; Kalifa C; Gouyette A
Int J Cancer; 1996 Apr; 69(2):146-51. PubMed ID: 8608984
[TBL] [Abstract][Full Text] [Related]
10. Establishment and characterization of human medulloblastoma xenograft line.
Mikami T; Kurisu K; Kawamoto K; Kiya K; Mukada K; Hotta T; Ogasawara H; Sugiyama K; Uozumi T
Hiroshima J Med Sci; 1991 Mar; 40(1):41-5. PubMed ID: 1864766
[TBL] [Abstract][Full Text] [Related]
11. c-myc overexpression causes anaplasia in medulloblastoma.
Stearns D; Chaudhry A; Abel TW; Burger PC; Dang CV; Eberhart CG
Cancer Res; 2006 Jan; 66(2):673-81. PubMed ID: 16423996
[TBL] [Abstract][Full Text] [Related]
12. Establishment of a human medulloblastoma cell line and its heterotransplantation into nude mice.
Jacobsen PF; Jenkyn DJ; Papadimitriou JM
J Neuropathol Exp Neurol; 1985 Sep; 44(5):472-85. PubMed ID: 2993532
[TBL] [Abstract][Full Text] [Related]
13. Large-cell medulloblastomas. A distinct variant with highly aggressive behavior.
Giangaspero F; Rigobello L; Badiali M; Loda M; Andreini L; Basso G; Zorzi F; Montaldi A
Am J Surg Pathol; 1992 Jul; 16(7):687-93. PubMed ID: 1530108
[TBL] [Abstract][Full Text] [Related]
14. Low-level copy gain versus amplification of myc oncogenes in medulloblastoma: utility in predicting prognosis and survival. Laboratory investigation.
Takei H; Nguyen Y; Mehta V; Chintagumpala M; Dauser RC; Adesina AM
J Neurosurg Pediatr; 2009 Jan; 3(1):61-5. PubMed ID: 19119907
[TBL] [Abstract][Full Text] [Related]
15. Differential forms of p53 in medulloblastoma primary tumors, cell lines and xenografts.
Philipova T; Baryawno N; Hartmann W; Pietsch T; Druid H; Johnsen JI; Ekström TJ
Int J Oncol; 2011 Mar; 38(3):843-9. PubMed ID: 21184030
[TBL] [Abstract][Full Text] [Related]
16. Large cell/anaplastic medulloblastoma: outcome according to myc status, histopathological, and clinical risk factors.
von Hoff K; Hartmann W; von Bueren AO; Gerber NU; Grotzer MA; Pietsch T; Rutkowski S
Pediatr Blood Cancer; 2010 Mar; 54(3):369-76. PubMed ID: 19908297
[TBL] [Abstract][Full Text] [Related]
17. Differentiation characteristics of newly established medulloblastoma cell lines (D384 Med, D425 Med, and D458 Med) and their transplantable xenografts.
He XM; Wikstrand CJ; Friedman HS; Bigner SH; Pleasure S; Trojanowski JQ; Bigner DD
Lab Invest; 1991 Jun; 64(6):833-43. PubMed ID: 1904513
[TBL] [Abstract][Full Text] [Related]
18. In vitro and in vivo variation in transferrin receptor expression on a human medulloblastoma cell line.
Wen DY; Hall WA; Conrad J; Godal A; Flørenes VA; Fodstad O
Neurosurgery; 1995 Jun; 36(6):1158-63; discussion 1163-4. PubMed ID: 7643997
[TBL] [Abstract][Full Text] [Related]
19. Specific and high-level targeting of radiolabeled octreotide analogues to human medulloblastoma xenografts.
Vaidyanathan G; Friedman HS; Affleck DJ; Schottelius M; Wester HJ; Zalutsky MR
Clin Cancer Res; 2003 May; 9(5):1868-76. PubMed ID: 12738745
[TBL] [Abstract][Full Text] [Related]
20. Establishment and characterization of an orthotopic patient-derived Group 3 medulloblastoma model for preclinical drug evaluation.
Sandén E; Dyberg C; Krona C; Gallo-Oller G; Olsen TK; Enríquez Pérez J; Wickström M; Estekizadeh A; Kool M; Visse E; Ekström TJ; Siesjö P; Johnsen JI; Darabi A
Sci Rep; 2017 Apr; 7():46366. PubMed ID: 28417956
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
